drug reimbursement

Biopharma Re-engages Thought Leader Select for KOL Work in Bacterial Infections

December 10, 2013 (CHAPEL HILL, NC) Thought Leader Select, a consulting firm to the life sciences industries, recently earned a new client engagement to support key opinion leader (KOL) strategies for new treatments in the area of bacterial infections. The client company, an industry leader in the development of medications to treat various bacterial infections, tabbed …

Biopharma Re-engages Thought Leader Select for KOL Work in Bacterial Infections Read More »

Pharma Faces Longer Approval Times, Lower Reimbursement Rates in Years Ahead—Effective Payer KOLs the Answer

Pharmaceutical manufacturers will face longer regulatory approval times and lower reimbursement rates in the years ahead according to new IMS data. A recent IMS release summarizes market forecasting data, including reduced drug spending by public payers and more extensive reviews of new therapies. To navigate effectively through these new challenges, pharmaceutical companies will need a …

Pharma Faces Longer Approval Times, Lower Reimbursement Rates in Years Ahead—Effective Payer KOLs the Answer Read More »